查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
短肠症候群市场 - 全球市场规模、份额、趋势分析、机会和预测报告，2019-2029
市场调查报告书
商品编码
1334442

短肠症候群市场 - 全球市场规模、份额、趋势分析、机会和预测报告，2019-2029

Short Bowel Syndrome Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Type ; By Distribution Channel ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

到 2029 年，全球短肠症候群市场将超过 20 亿美元

由于肠外营养成本高昂和短肠症候群肠综合征患病率不断增加，对 SBS 治疗药物的需求不断增加，全球短肠症候群(SBS) 市场正在蓬勃发展。

领先的战略咨询和市场研究公司 BlueWeave Consulting 最近估计 2022 年全球短肠症候群市场规模为 8.2829 亿美元。 BlueWeave 预测，2023-2029 年预测期内，全球短肠症候群市场规模将以 14.05% 的年复合成长率大幅扩张，到 2029 年达到 20.5324 亿美元。胃肠道疾病患病率的上升、医疗技术的进步以及医疗保健专业人员和患者意识的提高是全球短肠症候群市场的一些关键增长促进因素。短肠症候群的发病率在全球范围内呈上升趋势，主要是由于胃肠道手术、先天性异常、炎症性肠病和其他导致大部分小肠切除或失败的因素所致。患病率的增加产生了对有效治疗方案的需求。医疗技术的进步在短肠症候群创新疗法的开发中发挥了重要作用。这些进步包括肠外营养解决方案、肠移植手术、肠道康復计划等，改善患者的治疗效果并促进市场增长。此外，製药公司和研究机构正在积极投资研发，以发现和开发短肠症候群的新疗法。这些努力旨在改善患者的生活质量并解决该领域现有的未满足的医疗需求。因此，预计这些因素将在整个预测期内推动全球短肠症候群市场的扩张。然而，SBS 治疗的高成本和 SBS 的长期并发症预计将在分析期间抑制整体市场的增长。

该报告的详细分析提供了有关全球短肠症候群市场的增长潜力、未来趋势和统计数据的信息。它还涵盖了推动市场总规模预测的因素。该报告致力于提供全球短肠症候群市场的最新技术发展以及行业见解，帮助决策者做出明智的战略决策。它还分析了市场的增长促进因素、挑战和竞争力。

目录

第1章研究框架

第2章执行摘要

第3章全球短肠症候群市场洞察

  • 行业价值链分析
  • DROC分析
    • 增长促进因素
      • 短肠症候群患病率增加
      • 由于肠外营养成本飙升，对 SBS 药物的需求增加
    • 抑制因素
      • SBS治疗费用昂贵
      • SBS 的长期并发症
    • 机会
      • 新 SBS 药物和治疗方法的开发
      • 与其他公司的伙伴关係和协作
    • 任务
      • 严格的法规要求
      • 与仿製药的竞争
  • 技术进步/最新发展
  • 法律规范
  • 波特五力分析

第4章全球短肠症候群市场概述

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按类型
      • GLP-2
      • 生长激素
      • 谷氨酰胺
      • 其他的
    • 按分销渠道
      • 医院药房
      • 零售药房
      • 其他的
    • 按地区
      • 北美
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第5章北美短肠症候群市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按类型
    • 按分销渠道
    • 按国家/地区
      • 美国
      • 加拿大

第6章欧洲短肠症候群市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按类型
    • 按分销渠道
    • 按国家/地区
      • 德国
      • 英国
      • 意大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 其他欧洲国家

第7章亚太短肠症候群市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按类型
    • 按分销渠道
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳大利亚和新西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太地区其他地区

第8章拉丁美洲短肠症候群市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按类型
    • 按分销渠道
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 拉丁美洲其他地区

第9章中东和非洲短肠症候群市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按类型
    • 按分销渠道
    • 按国家/地区
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
      • 卡塔尔
      • 科威特
      • 南非
      • 尼日利亚
      • 阿尔及利亚
      • MEA 的其余部分

第10章竞争格局

  • 主要企业及其产品列表
  • 2022 年全球短肠症候群市场份额分析
  • 通过运行参数进行竞争基准测试
  • 主要战略发展（合併、收购、合作伙伴关係等）

第11章COVID-19 对全球短肠症候群市场的影响

第12章公司简介（公司简介、财务矩阵、竞争格局、关键人才、主要竞争、联繫地址、战略展望、SWOT分析）

  • Takeda
  • Emmaus Life Sciences
  • Nutricia（Danone）
  • Merck KGaA
  • GlyPharma Therapeutics
  • Zealand Pharma
  • Sancilio Pharmaceuticals
  • Naia Pharmaceuticals
  • Ardelyx
  • Adocia
  • Aralez Pharmaceuticals
  • Shield Therapeutics
  • OxThera
  • Rhythm Pharmaceuticals
  • Pivot Pharmaceuticals
  • Other Prominent Players

第13章关键战略建议

第14章调查方法

  • 定性研究
    • 初级和次级研究
  • 定量研究
  • 市场细分和资料三角测量
    • 二次调查
    • 初步调查
  • 主要调查受访者的地区分布
  • 假设和限制

* 也可随时提供非上市公司的财务信息。

简介目录
Product Code: BWC23628

Global Short Bowel Syndrome Market Size Booming to Cross USD 2 Billion by 2029.

Global short bowel syndrome (SBS) market is flourishing because of an increasing demand for SBS drugs due to the high cost of parenteral nutrition and the growing prevalence of short bowel syndrome.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global short bowel syndrome market size at USD 828.29 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global short bowel syndrome market size to expand at a significant CAGR of 14.05% reaching a value of USD 2,053.24 million by 2029. Major growth drivers for the global short bowel syndrome market include an increasing prevalence of gastrointestinal disorders, advancements in medical technology, and growing awareness among healthcare professionals and patients. The incidence of short bowel syndrome is rising globally, primarily due to factors such as gastrointestinal surgeries, congenital anomalies, inflammatory bowel diseases, and other conditions leading to the removal or dysfunction of a significant portion of the small intestine. This growing prevalence has created a demand for effective treatment options. Advancements in medical technology have played a crucial role in the development of innovative therapies for short bowel syndrome. These advancements encompass parenteral nutrition solutions, intestinal transplantation procedures, and intestinal rehabilitation programs, which have improved patient outcomes and are contributing to market growth. Also, pharmaceutical companies and research organizations are actively investing in research and development efforts to discover and develop new treatment options for short bowel syndrome. These initiatives aim to enhance patients' quality of life and address the existing unmet medical needs in this field. As a result, these factors are expected to drive the expansion of the global short bowel syndrome market throughout the forecast period. However, the high cost of SBS treatment and long-term complications of SBS are anticipated to restrain the overall market growth during the period in analysis.

Global Short Bowel Syndrome Market - Overview:

The global Short Bowel Syndrome (SBS) market encompasses the diagnosis, treatment, and management of a condition characterized by the loss or dysfunction of a significant portion of the small intestine. It involves pharmaceutical companies, medical device manufacturers, research organizations, and healthcare providers. Key products and services include pharmacological therapies, parenteral nutrition solutions, medical devices, surgical interventions, rehabilitation programs, and support services. The market is driven by factors such as the rising prevalence of gastrointestinal disorders, advancements in medical technology, research and development investments, and the need for effective SBS management. Market players strive to develop innovative therapies and interventions to improve patient outcomes and quality of life.

Impact of COVID-19 on Global Short Bowel Syndrome Market:

COVID-19 pandemic adversely affected the global short bowel syndrome market. The healthcare systems' focus on managing COVID-19 cases, disruptions in the supply chain, and restrictions on non-essential healthcare services have affected the diagnosis, treatment, and management of SBS. Clinical trials for new therapies and medical device development have been delayed or halted, impacting research and development activities. Also, the economic impact of the pandemic has affected healthcare budgets, potentially limiting patients' access to expensive SBS treatments. However, as the situation improved, the market gradually recovered, supported by increased healthcare investments and a resurgence in research and development efforts.

Global Short Bowel Syndrome Market - By Type:

By type, the global short bowel syndrome market is divided into GLP-2, Growth Hormone, and Glutamine segments. The GLP-2 (glucagon-like peptide-2) segment holds the highest share in the global Short Bowel Syndrome (SBS) market due to its effectiveness in managing the condition. GLP-2 is a hormone that plays a crucial role in promoting intestinal growth, enhancing nutrient absorption, and reducing fluid loss. It has shown promising results in clinical trials and is approved for the treatment of SBS in several regions. GLP-2 therapies, such as Teduglutide, have demonstrated the ability to reduce dependence on parenteral nutrition and improve intestinal function. The proven efficacy of GLP-2 treatments has led to their widespread adoption, contributing to the segment's dominant market share in the global SBS market.

Competitive Landscape:

Major players operating in the global short bowel syndrome market include: Takeda, Emmaus Life Sciences, Nutricia (Danone), Merck KGaA, GlyPharma Therapeutics, Zealand Pharma, Sancilio Pharmaceuticals, Naia Pharmaceuticals, Ardelyx, Adocia, Aralez Pharmaceuticals, Shield Therapeutics, OxThera, Rhythm Pharmaceuticals, and Pivot Pharmaceuticals. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Short Bowel Syndrome Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Short Bowel Syndrome Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Short Bowel Syndrome Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing prevalence of short bowel syndrome
      • 3.2.1.2. Growing demand for SBS drugs due to the high cost of parenteral nutrition
    • 3.2.2. Restraints
      • 3.2.2.1. High cost of SBS treatment
      • 3.2.2.2. Long-term complications of SBS
    • 3.2.3. Opportunities
      • 3.2.3.1. Development of new SBS drugs and therapies
      • 3.2.3.2. Partnerships and collaborations with other companies
    • 3.2.4. Challenges
      • 3.2.4.1. Stringent regulatory requirements
      • 3.2.4.2. Competition from generic drugs
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Short Bowel Syndrome Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Type
      • 4.2.1.1. GLP-2
      • 4.2.1.2. Growth Hormone
      • 4.2.1.3. Glutamine
      • 4.2.1.4. Others
    • 4.2.2. By Distribution Channel
      • 4.2.2.1. Hospital Pharmacies
      • 4.2.2.2. Retail Pharmacies
      • 4.2.2.3. Others
    • 4.2.3. By Region
      • 4.2.3.1. North America
      • 4.2.3.2. Europe
      • 4.2.3.3. Asia Pacific (APAC)
      • 4.2.3.4. Latin America (LATAM)
      • 4.2.3.5. Middle East and Africa (MEA)

5. North America Short Bowel Syndrome Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Distribution Channel
    • 5.2.3. By Country
      • 5.2.3.1. United States
      • 5.2.3.1.1. By Type
      • 5.2.3.1.2. By Distribution Channel
      • 5.2.3.2. Canada
      • 5.2.3.2.1. By Type
      • 5.2.3.2.2. By Distribution Channel

6. Europe Short Bowel Syndrome Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Country
      • 6.2.3.1. Germany
      • 6.2.3.1.1. By Type
      • 6.2.3.1.2. By Distribution Channel
      • 6.2.3.2. United Kingdom
      • 6.2.3.2.1. By Type
      • 6.2.3.2.2. By Distribution Channel
      • 6.2.3.3. Italy
      • 6.2.3.3.1. By Type
      • 6.2.3.3.2. By Distribution Channel
      • 6.2.3.4. France
      • 6.2.3.4.1. By Type
      • 6.2.3.4.2. By Distribution Channel
      • 6.2.3.5. Spain
      • 6.2.3.5.1. By Type
      • 6.2.3.5.2. By Distribution Channel
      • 6.2.3.6. Belgium
      • 6.2.3.6.1. By Type
      • 6.2.3.6.2. By Distribution Channel
      • 6.2.3.7. Russia
      • 6.2.3.7.1. By Type
      • 6.2.3.7.2. By Distribution Channel
      • 6.2.3.8. Rest of Europe
      • 6.2.3.8.1. By Type
      • 6.2.3.8.2. By Distribution Channel

7. Asia Pacific Short Bowel Syndrome Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
      • 7.2.3.1. China
      • 7.2.3.1.1. By Type
      • 7.2.3.1.2. By Distribution Channel
      • 7.2.3.2. India
      • 7.2.3.2.1. By Type
      • 7.2.3.2.2. By Distribution Channel
      • 7.2.3.3. Japan
      • 7.2.3.3.1. By Type
      • 7.2.3.3.2. By Distribution Channel
      • 7.2.3.4. South Korea
      • 7.2.3.4.1. By Type
      • 7.2.3.4.2. By Distribution Channel
      • 7.2.3.5. Australia & New Zealand
      • 7.2.3.5.1. By Type
      • 7.2.3.5.2. By Distribution Channel
      • 7.2.3.6. Indonesia
      • 7.2.3.6.1. By Type
      • 7.2.3.6.2. By Distribution Channel
      • 7.2.3.7. Malaysia
      • 7.2.3.7.1. By Type
      • 7.2.3.7.2. By Distribution Channel
      • 7.2.3.8. Singapore
      • 7.2.3.8.1. By Type
      • 7.2.3.8.2. By Distribution Channel
      • 7.2.3.9. Vietnam
      • 7.2.3.9.1. By Type
      • 7.2.3.9.2. By Distribution Channel
      • 7.2.3.10. Rest of APAC
      • 7.2.3.10.1. By Type
      • 7.2.3.10.2. By Distribution Channel

8. Latin America Short Bowel Syndrome Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
      • 8.2.3.1. Brazil
      • 8.2.3.1.1. By Type
      • 8.2.3.1.2. By Distribution Channel
      • 8.2.3.2. Mexico
      • 8.2.3.2.1. By Type
      • 8.2.3.2.2. By Distribution Channel
      • 8.2.3.3. Argentina
      • 8.2.3.3.1. By Type
      • 8.2.3.3.2. By Distribution Channel
      • 8.2.3.4. Peru
      • 8.2.3.4.1. By Type
      • 8.2.3.4.2. By Distribution Channel
      • 8.2.3.5. Rest of LATAM
      • 8.2.3.5.1. By Type
      • 8.2.3.5.2. By Distribution Channel

9. Middle East & Africa Short Bowel Syndrome Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
      • 9.2.3.1. Saudi Arabia
      • 9.2.3.1.1. By Type
      • 9.2.3.1.2. By Distribution Channel
      • 9.2.3.2. UAE
      • 9.2.3.2.1. By Type
      • 9.2.3.2.2. By Distribution Channel
      • 9.2.3.3. Qatar
      • 9.2.3.3.1. By Type
      • 9.2.3.3.2. By Distribution Channel
      • 9.2.3.4. Kuwait
      • 9.2.3.4.1. By Type
      • 9.2.3.4.2. By Distribution Channel
      • 9.2.3.5. South Africa
      • 9.2.3.5.1. By Type
      • 9.2.3.5.2. By Distribution Channel
      • 9.2.3.6. Nigeria
      • 9.2.3.6.1. By Type
      • 9.2.3.6.2. By Distribution Channel
      • 9.2.3.7. Algeria
      • 9.2.3.7.1. By Type
      • 9.2.3.7.2. By Distribution Channel
      • 9.2.3.8. Rest of MEA
      • 9.2.3.8.1. By Type
      • 9.2.3.8.2. By Distribution Channel

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Short Bowel Syndrome Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Short Bowel Syndrome Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Takeda
  • 12.2. Emmaus Life Sciences
  • 12.3. Nutricia (Danone)
  • 12.4. Merck KGaA
  • 12.5. GlyPharma Therapeutics
  • 12.6. Zealand Pharma
  • 12.7. Sancilio Pharmaceuticals
  • 12.8. Naia Pharmaceuticals
  • 12.9. Ardelyx
  • 12.10. Adocia
  • 12.11. Aralez Pharmaceuticals
  • 12.12. Shield Therapeutics
  • 12.13. OxThera
  • 12.14. Rhythm Pharmaceuticals
  • 12.15. Pivot Pharmaceuticals
  • 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

Figures

  • Figure 1 Global Short Bowel Syndrome Market Segmentation
  • Figure 2 Global Short Bowel Syndrome Market Value Chain Analysis
  • Figure 3 Company Market Share Analysis, 2022
  • Figure 4 Global Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 5 Global Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 6 Global Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 7 Global Short Bowel Syndrome Market Share, By Region, By Value, 2019-2029
  • Figure 8 North America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 9 North America Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 10 North America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 11 North America Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
  • Figure 12 United States Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 13 United States Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 14 United States Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 15 Canada Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 16 Canada Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 17 Canada Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 18 Europe Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 19 Europe Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 20 Europe Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 21 Europe Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
  • Figure 22 Germany Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 23 Germany Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 24 Germany Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 25 United Kingdom Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 26 United Kingdom Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 27 United Kingdom Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 28 Italy Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 29 Italy Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 30 Italy Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 31 France Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 32 France Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 33 France Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 34 Spain Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 35 Spain Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 36 Spain Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 37 Belgium Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 38 Belgium Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 39 Belgium Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 40 Rest of Europe Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 41 Rest of Europe Short Bowel Syndrome Market Share, By Technology, By Value, 2019-2029
  • Figure 42 Rest of Europe Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 43 The Asia-Pacific Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 44 The Asia-Pacific Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 45 The Asia-Pacific Short Bowel Syndrome Market Share, By Deployment, By Value, 2019-2029
  • Figure 46 The Asia-Pacific Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
  • Figure 47 China Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 48 China Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 49 China Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 50 India Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 51 India Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 52 India Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 53 Japan Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 54 Japan Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 55 Japan Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 56 South Korea Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 57 South Korea Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 58 South Korea Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 59 Australia & New Zealand Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 60 Australia & New Zealand Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 61 Australia & New Zealand Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 62 Indonesia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 63 Indonesia Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 64 Indonesia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 65 Malaysia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 66 Malaysia Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 67 Malaysia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 68 Singapore Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 69 Singapore Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 70 Singapore Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 71 Vietnam Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 72 Vietnam Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 73 Vietnam Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 74 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 75 Rest of Asia Pacific Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 76 Rest of Asia Pacific Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 77 Latin America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 78 Latin America Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 79 Latin America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 80 Latin America Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
  • Figure 81 Brazil Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 82 Brazil Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 83 Brazil Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 84 Mexico Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 85 Mexico Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 86 Mexico Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 87 Argentina Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 88 Argentina Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 89 Argentina Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 90 Peru Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 91 Peru Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 92 Peru Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 93 Rest of Latin America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 94 Rest of Latin America Short Bowel Syndrome Market Share, By Type By Value, 2019-2029
  • Figure 95 Rest of Latin America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 96 The Middle East & Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 97 The Middle East & Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 98 The Middle East & Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 99 The Middle East & Africa Short Bowel Syndrome Market Share, By Country, By Value, 2019-2029
  • Figure 100 Saudi Arabia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 101 Saudi Arabia Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 102 Saudi Arabia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 103 UAE Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 104 UAE Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 105 UAE Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 106 Qatar Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 107 Qatar Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 108 Qatar Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 109 Kuwait Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 110 Kuwait Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 111 Kuwait Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 112 Iran Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 113 Iran Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 114 Iran Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 115 South Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 116 South Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 117 South Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 118 Nigeria Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 119 Nigeria Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 120 Nigeria Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 121 Kenya Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 122 Kenya Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 123 Kenya Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 124 Egypt Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 125 Egypt Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 126 Egypt Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 127 Morocco Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 128 Morocco Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 129 Morocco Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 130 Algeria Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 131 Algeria Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 132 Algeria Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029
  • Figure 133 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019-2029
  • Figure 134 Rest of Middle East & Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019-2029
  • Figure 135 Rest of Middle East & Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019-2029

Tables

  • Table 1 Global Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 2 Global Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 3 Global Short Bowel Syndrome Market Size, By Region, By Value, 2019-2029
  • Table 4 North America Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 5 North America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 6 North America Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
  • Table 7 United States Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 8 United States Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 9 Canada Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 10 Canada Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 11 Europe Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 12 Europe Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 13 Europe Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
  • Table 14 Germany Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 15 Germany Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 16 United Kingdom Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 17 United Kingdom Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 18 Italy Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 19 Italy Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 20 France Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 21 France Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 22 Spain Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 23 Spain Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 24 Belgium Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 25 Belgium Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 26 Rest of Europe Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 27 Rest of Europe Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 28 The Asia-Pacific Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 29 The Asia-Pacific Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 30 The Asia-Pacific Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
  • Table 31 China Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 32 China Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 33 India Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 34 India Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 35 Japan Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 36 Japan Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 37 South Korea Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 38 South Korea Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 39 Australia & New Zealand Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 40 Australia & New Zealand Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 41 Indonesia Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 42 Indonesia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 43 Malaysia Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 44 Malaysia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 45 Singapore Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 46 Singapore Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 47 Philippines Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 48 Philippines Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 49 Vietnam Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 50 Vietnam Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 51 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 52 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 53 Latin America Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 54 Latin America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 55 Latin America Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
  • Table 56 Brazil Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 57 Brazil Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 58 Mexico Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 59 Mexico Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 60 Argentina Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 61 Argentina Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 62 Peru Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 63 Peru Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 64 Rest of Latin America Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 65 Rest of Latin America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 66 The Middle East & Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 67 The Middle East & Africa Short Bowel Syndrome Market Size, By Country, By Value, 2019-2029
  • Table 68 Saudi Arabia Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 69 Saudi Arabia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 70 UAE Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 71 UAE Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 72 Qatar Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 73 Qatar Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 74 Kuwait Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 75 Kuwait Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 76 Iran Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 77 Iran Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 78 South Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 79 South Africa Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 80 Nigeria Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 81 Nigeria Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 82 Kenya Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 83 Kenya Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 84 Egypt Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 85 Egypt Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 86 Morocco Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 87 Morocco Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 88 Algeria Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 89 Algeria Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 90 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019-2029
  • Table 91 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019-2029
  • Table 92 Takeda Company Overview
  • Table 93 Takeda Financial Overview
  • Table 94 Emmaus Life Sciences Company Overview
  • Table 95 Emmaus Life Sciences Financial Overview
  • Table 96 Nutricia (Danone) Company Overview
  • Table 97 Nutricia (Danone) Financial Overview
  • Table 98 Merck KGaA Company Overview
  • Table 99 Merck KGaA Financial Overview
  • Table 100 GlyPharma Therapeutics Company Overview
  • Table 101 GlyPharma Therapeutics Financial Overview
  • Table 102 Zealand Pharma Company Overview
  • Table 103 Zealand Pharma Financial Overview
  • Table 104 Sancilio Pharmaceuticals Company Overview
  • Table 105 Sancilio Pharmaceuticals Financial Overview
  • Table 106 Naia Pharmaceuticals Company Overview
  • Table 107 Naia Pharmaceuticals Financial Overview
  • Table 108 Ardelyx Company Overview
  • Table 109 Ardelyx Financial Overview
  • Table 110 Adocia Company Overview
  • Table 111 Adocia Financial Overview
  • Table 112 Aralez Pharmaceuticals Company Overview
  • Table 113 Aralez Pharmaceuticals Financial Overview
  • Table 114 Pivot Pharmaceuticals Company Overview
  • Table 115 Pivot Pharmaceuticals Financial Overview
  • Table 116 Other Prominent Players Company Overview
  • Table 117 Other Prominent Players Financial Overview